Ganaxolone as a promising therapeutic agent for Alzheimer’s disease: signaling pathways and mechanistic insights—a narrative review

Puntos clave

• Ganaxolone shows potential as a therapeutic agent for Alzheimer's disease, targeting key signaling pathways.
• Significant insights reveal how ganaxolone interacts with neurodegeneration mechanisms, providing a basis for treatment.
• Narrative review discusses various mechanistic insights from multiple sources, offering a comprehensive view.
• Implications indicate that further investigation into ganaxolone's role is essential to validate its efficacy in clinical settings.